Possis Medical, Inc.
Cardiovascular medical device company report study results, financials
Published in Telemedicine Business Week, September 22nd, 2004
The study was configured as a multicenter, prospective randomized two-arm trial comparing AngioJet thrombectomy followed by definitive treatment (angioplasty, stent and eptifibatide), versus immediate definitive treatment only, in patients undergoing intervention for acute myocardial infarction, or heart attack.
The study used the AngioJet XMI catheter, which has FDA approval for removing thrombus in native coronary arteries and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
More Articles from Telemedicine Business Week
- eResearchTechnology, Inc.
Europe-based multinational pharmaceutical company signs $900,000 study extension - SHL Telemedicine
Telemedicine company releases financial information - TriPath Imaging, Inc.
Cancer-focused company submits PMA for HPV test of cervical samples to U.S. FDA - TriPath Imaging, Inc.
Digene announces FDA submission for SurePath Test Pack - American Gastroenterological Association
Virtual colonoscopy shows significant promise, though some issues unresolved - Angina
Study shows no benefit from early PCI/CABG in high-risk unstable angina patients - More from this issue of Telemedicine Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
